CD274 and neoplasm: As the PDL-1/PD-1 interaction dampens anti-tumor T cell responses [23,24,25], the disruption of this pathway by anti-PD-1/PDL-1 monoclonal antibodies can revive worn-out T cells and prompt anti-tumor responses [26,27].